印度中风治疗的准备情况：仍是一项艰巨任务！
Readiness of the Stroke Treatment in India: Still an Uphill Task!
作者信息
Singhal Vasudha, Prabhakar Hemanshu
机构信息
Department of Neuroanaesthesiology and Critical Care, Medanta - The Medicity Hospital, Gurugram, Haryana, India.
Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India.
出版信息
Indian J Crit Care Med. 2023 Sep;27(9):607-608. doi: 10.5005/jp-journals-10071-24525.
Abstract
: Singhal V, Prabhakar H. Readiness of the Stroke Treatment in India: Still an Uphill Task! Indian J Crit Care Med 2023;27(9):607-608.
摘要
辛哈尔 V、普拉巴卡尔 H。印度中风治疗的准备情况：仍然是一项艰巨的任务！《印度重症监护医学杂志》2023 年；27(9)：607 - 608。
相似文献
1
Readiness of the Stroke Treatment in India: Still an Uphill Task!印度中风治疗的准备情况：仍是一项艰巨任务！
Indian J Crit Care Med. 2023 Sep;27(9):607-608. doi: 10.5005/jp-journals-10071-24525.
2
Stumbling Blocks to Stroke Thrombolysis: An Indian Perspective.中风溶栓的绊脚石：印度视角
Indian J Crit Care Med. 2023 Sep;27(9):616-619. doi: 10.5005/jp-journals-10071-24517.
3
Managing Meningoencephalitis in Indian ICU.印度重症监护病房中脑膜脑炎的管理
Indian J Crit Care Med. 2019 Jun;23(Suppl 2):S124-S128. doi: 10.5005/jp-journals-10071-23189.
4
Clinical Approach to Acute Decline in Sensorium.意识急性减退的临床处理方法
Indian J Crit Care Med. 2019 Jun;23(Suppl 2):S120-S123. doi: 10.5005/jp-journals-10071-23188.
5
Colistin for Treatment of Multidrug Resistant Central Nervous System Infection: A Triple Route Therapy!多黏菌素治疗多重耐药中枢神经系统感染：一种三联途径疗法！
Indian J Crit Care Med. 2019 Jun;23(6):287. doi: 10.5005/jp-journals-10071-23183.
6
The Menace of Meningitis!脑膜炎的威胁！
Indian J Crit Care Med. 2022 Dec;26(12):1231-1232. doi: 10.5005/jp-journals-10071-24368.
7
Acute Ischemic Stroke: Management Approach.急性缺血性卒中：治疗方法
Indian J Crit Care Med. 2019 Jun;23(Suppl 2):S140-S146. doi: 10.5005/jp-journals-10071-23192.
8
Author Response: Factors Requiring Improvement for Timely and Effective Treatment of Acute Stroke.作者回复：急性卒中及时有效治疗所需改进的因素。
Indian J Crit Care Med. 2023 Dec;27(12):949-950. doi: 10.5005/jp-journals-10071-24591.
9
Augmenting Hypertensive Therapy in Patients with Postoperative Subarachnoid Hemorrhage: What's the Right Choice?加强术后蛛网膜下腔出血患者的高血压治疗：正确选择是什么？
Indian J Crit Care Med. 2023 Apr;27(4):233-234. doi: 10.5005/jp-journals-10071-24441.
10
A Rare Case of Rhinocerebral Mucormycosis Presenting as Garcin Syndrome and Acute Ischemic Stroke.一例表现为加欣综合征和急性缺血性卒中的鼻脑毛霉菌病罕见病例。
Indian J Crit Care Med. 2020 Nov;24(11):1137-1138. doi: 10.5005/jp-journals-10071-23643.
本文引用的文献
1
Stumbling Blocks to Stroke Thrombolysis: An Indian Perspective.中风溶栓的绊脚石：印度视角
Indian J Crit Care Med. 2023 Sep;27(9):616-619. doi: 10.5005/jp-journals-10071-24517.
2
Stroke Thrombolysis: Beating the Clock.中风溶栓：分秒必争。
Indian J Crit Care Med. 2023 Feb;27(2):107-110. doi: 10.5005/jp-journals-10071-24405.
3
Essential Workflow and Performance Measures for Optimizing Acute Ischemic Stroke Treatment in India.优化印度急性缺血性卒中治疗的基本工作流程和绩效指标
Stroke. 2020 Jul;51(7):1969-1977. doi: 10.1161/STROKEAHA.119.026733. Epub 2020 Jun 17.
4
Editorial: Time is brain!社论：时间就是大脑！
J Stroke Cerebrovasc Dis. 1993;3(1):1-2. doi: 10.1016/S1052-3057(10)80125-9. Epub 2010 Jun 10.
5
Thrombolysis for stroke in India: miles to go..印度的中风溶栓治疗：任重道远……
Neurol India. 2007 Jan-Mar;55(1):3-5. doi: 10.4103/0028-3886.30415.
6
Knowledge of stroke among stroke patients and their relatives in Northwest India.印度西北部中风患者及其亲属对中风的认知情况。
Neurol India. 2006 Jun;54(2):152-6; discussion 156.
7
Public awareness of warning symptoms, risk factors, and treatment of stroke in northwest India.印度西北部公众对中风警示症状、风险因素及治疗的认知
Stroke. 2005 Mar;36(3):644-8. doi: 10.1161/01.STR.0000154876.08468.a0. Epub 2005 Jan 20.
8
Feasibility of acute thrombolytic therapy for stroke.急性脑卒中溶栓治疗的可行性
Neurol India. 2003 Dec;51(4):470-3.
9
A study of factors delaying hospital arrival of patients with acute stroke.
Neurol India. 2001 Sep;49(3):272-6.
10
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.症状出现后3至5小时使用重组组织型纤溶酶原激活剂（阿替普酶）治疗缺血性卒中。ATLANTIS研究：一项随机对照试验。阿替普酶用于缺血性卒中急性非介入治疗的溶栓研究。
JAMA. 1999 Dec 1;282(21):2019-26. doi: 10.1001/jama.282.21.2019.
Zotero 插件